• Pharma
  • May 30, 2025
  • 433 views
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…

  • Pharma
  • April 11, 2025
  • 586 views
Aurobindo Pharma shares jump 4% as arm completes phase1 trial for bone drug

Aurobindo Pharma shares jumped 5 per cent on Friday, April 11, 2025, logging an intraday high at ₹1,110 per share on BSE. The stock rallied after the company’s subsidiary, CuraTeQ…

  • Pharma
  • January 28, 2025
  • 470 views
Aurobindo Pharma’s API unit in Telangana gets VAI status from USFDA

Aurobindo Pharma on Tuesday, January 28, said the United States Food and Drug Administration (USFDA) has issued an establishment inspection report (EIR) to its subsidiary’s active pharmaceutical ingredient (API) facility in…